Search research articles
Contact Us
Filters
Showing results (61-70 of 374) with videos related to
Page
of 38
Sort By:
Ejhaem
|
November 29, 2023
Critical gaps in understanding treatment outcomes in adolescents and young adults with lymphoma: A review of current data
Priyanka A Pophali, Lindsay M Morton, Susan K Parsons, et al.
JAMA
|
September 7, 2006
Association of perceived medical errors with resident distress and empathy: a prospective longitudinal study
Colin P West, Mashele M Huschka, Paul J Novotny, et al.
International Journal of Cancer
|
August 18, 2009
Antioxidant intake from fruits, vegetables and other sources and risk of non-Hodgkin's lymphoma: the Iowa Women's Health Study
Carrie A Thompson, Thomas M Habermann, Alice H Wang, et al.
Leukemia & Lymphoma
|
September 16, 2011
Cardiac toxicity associated with bevacizumab (Avastin) in combination with CHOP chemotherapy for peripheral T cell lymphoma in ECOG 2404 trial
Ranjana H Advani, Fangxin Hong, Sandra J Horning, et al.
Thyroid : Official Journal of the American Thyroid Association
|
June 4, 2016
Clinical Presentation and Diagnostic Challenges of Thyroid Lymphoma: A Cohort Study
Anu Sharma, Sina Jasim, Carl C Reading, et al.
Cancer
|
February 19, 2010
The treatment of recurrent/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL) with everolimus results in clinical responses and mobilization of CLL cells into the circulation
Clive S Zent, Betsy R LaPlant, Patrick B Johnston, et al.
International Journal of Dermatology
|
July 9, 2002
Treatment of late-stage Sézary syndrome with 2-Chlorodeoxyadenosine
Saskia A Bouwhuis, Rokea A el-Azhary, Marian T McEvoy, et al.
Blood Cancer Journal
|
October 16, 2025
EBV+ polymorphic B-cell lymphoproliferative disorder, NOS: a single-center study of a newly recognized pathologic entity
Suheil Albert Atallah-Yunes, Thomas M Habermann, Matthew J Rees, et al.
Blood
|
November 17, 2007
SYK-dependent tonic B-cell receptor signaling is a rational treatment target in diffuse large B-cell lymphoma
Linfeng Chen, Stefano Monti, Przemyslaw Juszczynski, et al.
Blood Cancer Journal
|
January 6, 2022
Efficacy of front-line immunochemotherapy for follicular lymphoma: a network meta-analysis of randomized controlled trials
Yucai Wang, Shouhao Zhou, Xinyue Qi, et al.
Page
of 38
Search research articles
Search
Showing results (61-70 of 374) with videos related to
Sort By:
Page
of 38
Ejhaem
|
November 29, 2023
Critical gaps in understanding treatment outcomes in adolescents and young adults with lymphoma: A review of current data
Priyanka A Pophali, Lindsay M Morton, Susan K Parsons, et al.
JAMA
|
September 7, 2006
Association of perceived medical errors with resident distress and empathy: a prospective longitudinal study
Colin P West, Mashele M Huschka, Paul J Novotny, et al.
International Journal of Cancer
|
August 18, 2009
Antioxidant intake from fruits, vegetables and other sources and risk of non-Hodgkin's lymphoma: the Iowa Women's Health Study
Carrie A Thompson, Thomas M Habermann, Alice H Wang, et al.
Leukemia & Lymphoma
|
September 16, 2011
Cardiac toxicity associated with bevacizumab (Avastin) in combination with CHOP chemotherapy for peripheral T cell lymphoma in ECOG 2404 trial
Ranjana H Advani, Fangxin Hong, Sandra J Horning, et al.
Thyroid : Official Journal of the American Thyroid Association
|
June 4, 2016
Clinical Presentation and Diagnostic Challenges of Thyroid Lymphoma: A Cohort Study
Anu Sharma, Sina Jasim, Carl C Reading, et al.
Cancer
|
February 19, 2010
The treatment of recurrent/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL) with everolimus results in clinical responses and mobilization of CLL cells into the circulation
Clive S Zent, Betsy R LaPlant, Patrick B Johnston, et al.
International Journal of Dermatology
|
July 9, 2002
Treatment of late-stage Sézary syndrome with 2-Chlorodeoxyadenosine
Saskia A Bouwhuis, Rokea A el-Azhary, Marian T McEvoy, et al.
Blood Cancer Journal
|
October 16, 2025
EBV+ polymorphic B-cell lymphoproliferative disorder, NOS: a single-center study of a newly recognized pathologic entity
Suheil Albert Atallah-Yunes, Thomas M Habermann, Matthew J Rees, et al.
Blood
|
November 17, 2007
SYK-dependent tonic B-cell receptor signaling is a rational treatment target in diffuse large B-cell lymphoma
Linfeng Chen, Stefano Monti, Przemyslaw Juszczynski, et al.
Blood Cancer Journal
|
January 6, 2022
Efficacy of front-line immunochemotherapy for follicular lymphoma: a network meta-analysis of randomized controlled trials
Yucai Wang, Shouhao Zhou, Xinyue Qi, et al.
Page
of 38